SUMMARY This study characterized the effect of nucleus tractus solitarii (NTS) microinjection of the angiotensin II (Ang II) antagonist [Sar 1 ,Thr*]Ang II on the baroreceptor control of heart rate in anesthetized rats. Reflex changes in heart rate were elicited by bolus intravenous injections of either phenylephrine or sodium nitroprusslde before and after bilateral microinjection of [Sar l ,Thr*]Ang II (100 pmol) or vehicle into the NTS. The slope of the relationship between the change hi pulse Interval and the change in mean arterial pressure was used as an index of baroreceptor reflex sensitivity. Bradycardia elicited by phenylephrine-induced increases in pressure was significantly greater after NTS injection of [Sar 1 ,Thr*]Ang II. The slope of the pulse interval-arterial pressure relationship was 0.60 ± 0.09 ms/mm Hg after injection, as compared with 0.42 ± 0.07 ms/mm Hg before. In contrast, the baroreceptor reflex sensitivity index generated by decreases in pressure with nitroprusside was similar before and after injection. Vehicle injections did not alter the baroreceptor reflex index. Collectively, the data suggest that inhibition of endogenous Ang II in the NTS facilitates the baroreceptor reflex sensitivity to increases, but not decreases, in pressure. This new finding reveals the NTS as one site of action for the tonic effects of endogenous Ang II. 1 Ang II-sensitive areas have been identified in the brain, both within and outside of the blood-brain barrier.
M
ANY studies indicate that angiotensin II (Ang II) modulates baroreceptor reflex control of heart rate (HR) in part by altering the central integration of sensory information. 1 Ang II-sensitive areas have been identified in the brain, both within and outside of the blood-brain barrier. 2 "* In the lower brainstem, dense concentrations of specific highaffinity Ang II binding sites exist in the nucleus tractus solitarii (NTS) and dorsal motor nucleus of the vagus nerve (NX), with lower concentrations in the area postrema. 3 ' *~7 We recently showed that Ang II receptors in both rats and dogs are associated with vagal afferent fibers in the NTS and vagal motor neurons. 7 Besides containing a high density of Ang II receptors, the NTS is rich in ANG II-like immunoreactive nerve terminals and cell bodies, 3 suggesting that locally synthesized Ang II may modulate baroreceptor reflex function. Indeed, direct NTS microinjection of Ang II causes dose-dependent effects on mean arterial pressure (MAP) and HR, 8 -' 0 while Ang II infusions in the NTS attenuate the baroreceptor reflex control of HR." With this in mind, we evaluated the effect of NTS microinjection of the Ang II antagonist [Sar',Thr 8 ]Ang II on baroreceptor control of HR in rats.
Materials and Methods
Experiments were performed in 18 male SpragueDawley rats (Harlan Sprague-Dawley, Indianapolis, IN, USA) weighing 253 ± 2 g. After anesthesia with chloralose and urethane (50 mg/kg and 500 mg/kg i.p., respectively), catheters were inserted into a femoral artery and vein. Arterial pressure was continuously measured with a solid state strain gauge transducer (Model MP-15D, Micron Instruments, Los Angeles, CA, USA). HR was measured on a beat-by-beat basis by a cardiotachometer (Model 2000, Gould, Cleveland, OH, USA) triggered by the arterial pressure wave. All variables were displayed on a Gould polygraph (Series 2400).
Rats were placed in a stereotaxic frame (David Kopf Instruments, Tujunga, CA, USA) with the head flexed downward at 45 degrees. The dorsal surface of the medulla was exposed by incising the atlanto-occipital membrane. Bilateral microinjections of either 100 ng (100 pmol) of the Ang II antagonist [Sar',Thr 8 ]Ang II (M. Khosla, Cleveland, OH, USA) or artificial cerebrospinal fluid (aCSF) in a volume of 100 nl was made with a triple-barreled glass micropipette (30-50 /im outer diameter), as described previously. 8 In preliminary studies in four rats, this dose of the antagonist blocked the blood pressure response to an NTS injection of Ang II (500 fmol) for up to 30 minutes. ] Ang II was chosen over the antagonist saralasin because it has fewer agonistic effects and is a relatively long-acting blocker. ' 2 Injections were given over 1 minute by air pressure generated by hand-held syringe while the pipette was positioned in the NTS (0.5 mm rostral and 0.5 mm lateral to the obex, 0.3 mm below the dorsal surface).
Baroreceptor reflex control of HR was determined both before and after NTS microinjections in each rat by eliciting reflex HR changes in response to transient drug-induced variations in MAP. Korner et al. 13 demonstrated that such determinations are more sensitive to alterations in parasympathetic than sympathetic outflow compared with steady state responses produced by infusions of vasoactive agents. Repeated bolus injections of graded doses of phenylephrine (0.5-20 /ig/kg) or sodium nitroprusside (0.5-25 ^ig/kg), were given 1 to 2 minutes apart into a femoral vein in 0.1 ml of isotonic sodium chloride before and within 20 minutes after NTS injections of [Sar 1 .Thr*] Ang II. The order of injections was reversed in several experiments to control for decaying effects of the antagonist. Measurements were also obtained after intravenous injection of saline only. Peak changes in HR occurring during the initial 2 to 5 seconds of the corresponding maximum change in MAP produced with phenylephrine, sodium nitroprusside, or saline were recorded.
Pulse interval was calculated by the equation 60,000/HR (msec/beats/min).
14 The baroreceptor reflex sensitivity was estimated in each rat by fitting a least-squares regression line for the relationship between changes in pulse interval (msec) and MAP (mm Hg) for each data point obtained with graded injection of phenylephrine and nitroprusside. The slope of the line expressing this relationship (msec/mm Hg) was used as an index of baroreceptor reflex sensitivity, as proposed elsewhere." In addition, values were expressed as the AHR/AMAP ratio. Individual measurements of reflex sensitivity were then averaged for statistical comparisons. The data were evaluated by paired Student's t test (before and after NTS microinjection) and unpaired / test (for aCSF and [Sar At the end of every experiment, 50 nl of Alcian blue dye (2%) was injected bilaterally into the NTS. The brain was then removed and frozen; the location of each injection site was assessed by histological examination of 50-fim serial frontal cryostat sections stained with thionine. In four additional rats, m I-Ang II (monoiodinated; New England Nuclear, Boston, MA, USA) was microinjected into the NTS in a 100-nl volume to assess the spread of the injectate. After 20 minutes (which corresponded to the duration of the observations on baroreceptor reflex control of HR) the brain was removed, frozen, and sectioned (50 fim). Sections were then apposed to x-ray film (SB-5, Kodak, Rochester, NY, USA) for 2 to 4 weeks, and the dimensions of the images were microscopically quantitated.
Results
Basal values of MAP and HR were similar before NTS microinjections of either aCSF or the Ang II antagonist (Table 1) . A small but significant decrease in HR ( -1 3 ± 5 beats/min; p<0.05), sustained throughout the study, occurred without changes in the resting MAP in response to [Sar , unpaired i) . In contrast, the sensitivity of the baroreceptor reflex control of HR to decreases in MAP produced by nitroprusside was not affected regardless of whether the baroreceptor reflex sensitivity was expressed as the slope (see Table 1 and Figure 2A ) or as the AHR/AMAP ratio (data not shown). Microinjection of aCSF into the NTS did not change the slope of the regression line to either increases or decreases in MAP produced by phenylephrine or nitroprusside, respectively (see Table 1 and Figure 2B) .
Injection sites are shown diagrammatically in Figure 3 . Placement of pipette tips was confined to the medial portion of the NTS, as there was no Alcian blue dye deposited in the area postrema or NX. Autoradiographic analysis of the distribution of l25 I-Ang II injections into the NTS of four rats revealed that the injectate spread 462 ±175 fim in the rostrocaudal direction, 750 ± 76 fim in the dorsoventral plane, and 600 ± 83 (im in the mediolateral plane. 
Discussion
The data presented in this study show that bilateral injections of an Ang II antagonist confined to the NTS selectively facilitate the baroreceptor reflex control of HR in response to increases in MAP in anesthetized rats. These observations are consistent with the localization of Ang II specific binding sites in the NTS 6 ' 7 and the demonstration that direct microinjection of Ang II into this nucleus produces dose-related effects on MAP. ]Ang II injection into the NTS, the differences in reflex sensitivity cannot be attributed to changes in baseline MAP. Because basal HR decreased after Ang II antagonist injections, the data also suggest a small but tonic effect of the peptide on cardiac rate in anesthetized animals. This latter finding contrasts with the observations of Rettig et al. 10 who showed that similar doses of the Ang II antagonist saralasin produced increases in HR. Although reasons for this discrepancy are not apparent, differences may be related to die partial agonist actions of saralasin, the bilateral application of the antagonist in our study, or a combination of both.
It should be emphasized that our experiments were performed in rats under anesthesia, a state known to exhibit high levels of plasma renin. 17 Several studies have shown that anesthesia elevates the threshold for baroreceptor activation of vagal efferents and may even eliminate the response. 18 Thus, one possibility in our experiments is that anesthesia increased the amount of either blood or brain concentrations of Ang II. Therefore, even though the anesthetic effect did not modify the basal level of MAP or HR from normal conscious values, it may have unmasked an inhibitory effect of Ang II on baroreceptor reflex sensitivity.
Ang II exerts an inhibitory influence on baroreceptor reflex control of HR after either intravenous or intracerebroventricular administration, in many species.'-' *~2 1 The responses appear to be accompanied by withdrawal of parasympathetic tone to the heart and excitation of sympathetic vascular tone. 7 and Ang II-like immunoreactivity 3 in the dorsal medulla suggested this region as a site of action for this peptide. Indeed, Casto and Phillips" recently reported that injection of Ang II into the NTS attenuates the baroreceptor reflex sensitivity. That endogenous Ang II influences the baroreceptor reflex can be inferred from studies by Berecek et al., 25 in which selective increases in the baroreceptor reflex gain in response to increases in MAP were observed after intracerebroventricular infusion of captopril (a converting enzyme inhibitor) in both spontaneously hypertensive and Wistar-Kyoto rats. Our study extends these findings by providing a specific brain site for the actions of endogenous Ang II on baroreceptor reflex control of HR in normotensive rats.
The selective effect of the Ang II antagonist to facilitate the baroreceptor reflex only for increases in MAP may be related to a specific attenuation by Ang II of baroreceptor reflex-evoked activity in cardiac vagal efferent nerves. Ang II has been reported to selectively inhibit parasympathetic tone to the heart after peripheral administration. 20 In addition, Guo and Abboud 22 showed selective impairment of the baroreceptor reflex in response to increases in MAP during peripheral infusion of Ang II without changes in reflex control of HR in response to decreases in MAP. The present data confirm a selective action of Ang II to impair the sensitivity of the vagal component of baroreceptor control of HR to increases in MAP. Furthermore, the new findings suggest the NTS as one brain site for this selectivity of action. An alternative explanation that cannot be ruled out, however, is that multiple sites within the central nervous system are involved in regulating baroreceptor reflex control of parasympathetic outflow to the heart, as suggested by Reis and Cuenod. 26 It is possible that these sites can be reached or affected differently by Ang II given by intracerebroventricular or intravenous routes.
Taken together, the results of this study indicate that endogenous, as well as exogenous, Ang II may act on specific receptors in the NTS to modulate the central integration of the baroreceptor inputs. Whether the source of the endogenous Ang II is central, peripheral, or both remains to be determined.
